Could AI Predict Vasculitis and Spondyloarthritis?
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

Could AI Predict Vasculitis and Spondyloarthritis?

It’s no secret that receiving a rare disease diagnosis can take excess amounts of time. Various articles share that, on average, it takes anywhere from four to nine years for…

Continue Reading Could AI Predict Vasculitis and Spondyloarthritis?
Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)
Dr. Katz

Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)

Don't forget to read Part 1 of our interview. In Part 1, we discussed what chronic granulomatous disease (CGD) is, how it is treated, and how parents and physicians can identify an…

Continue Reading Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)
Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)

Don't forget to read Part 1 of our interview, where Todd discusses what acute lymphoblastic leukemia (ALL) is and why it is so important to raise awareness for ALL and other cancers. Today,…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)

Did you know that September is Childhood Cancer Awareness Month? Although September has just passed, it is still important to raise awareness of the many different forms of childhood cancer…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)
Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease
Source: Pixabay

Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease

FBXL4-related mitochondrial disease urgently requires new therapies. Unfortunately, this condition is often fatal by early ages (early to mid-childhood). Therefore, it is important to spur research into potential interventions or…

Continue Reading Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease
Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)
Dr. Evan Dellon

Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)

Before you read on, make sure you've checked out Part 1 of our interview, where we discussed what eosinophilic esophagitis is, its symptoms and diagnostic criteria, and why Dr. Dellon chose to…

Continue Reading Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)
Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
Source: https://unsplash.com/photos/ZHys6xN7sUE

Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs

  Many patients with ankylosing spondylitis (AS) could be treated with biologics – in particular, biologic disease-modifying antirheumatic drugs (DMARDs). However, this line of treatment is not efficacious nor well-tolerated…

Continue Reading Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs